1SXP — SCHOTT Pharma AG & Co. KGaA Share News
0.000.00%
Last trade - 00:00- €3.71bn
- €3.75bn
- €986.21m
Europe Research Roundup: Air France-KLM, Shell, Watches of Switzerland
Brief: Schott Pharma Q2 Revenues Up 11% YoY To Eur 274 Mln
Vials maker Schott Pharma slides on 2025 profit warning
Brief: Schott Pharma AG & Co. KGaA See FY 25 Impacted By Slower Growth From Syringes
Stifel resumes Gerresheimer with 'buy' on strong GLP-1 exposure
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
Germany's Douglas shares trading below price guidance at IPO (updated)
Brief: Schott Pharma Says To Expand In U.S. With New Prefillable Syringe Manufacturing Facility In Wilson, North Carolina
German perfume retailer Douglas plans Frankfurt IPO by end March (updated)
Europe Research Roundup: EasyJet, Hikma, Kosmos Energy
Europe Research Roundup: DS Smith, Frontier Developments Plc, IMCD NV
Europe Research Roundup: Hikma, Repsol, Ryanair
Factbox: How Novo Nordisk makes its weight-loss drug Wegovy
CVC-backed DKV Mobility suspends IPO plans -sources (updated)
CVC-backed DKV Mobility puts IPO plans on hold - sources
Brief: Schott Pharma Says Early Termination Of Stabilization Period for IPO And Full Exercise Of The Greenshoe Option